Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis

Male 0301 basic medicine Adolescent Short Report Antibodies, Monoclonal Colonoscopy 610 Medical sciences; Medicine Antibodies, Monoclonal, Humanized Inflammatory Bowel Diseases Arthritis, Juvenile canakinumab 3. Good health Interleukin 1 Receptor Antagonist Protein systemic JIA 03 medical and health sciences Treatment Outcome 0302 clinical medicine ddc: 610 Rheumatology inflammatory bowel disease Antirheumatic Agents Immunology and Allergy Humans Pediatrics, Perinatology, and Child Health anakinra
DOI: 10.1186/s12969-017-0147-3 Publication Date: 2017-03-14T03:24:29Z
ABSTRACT
Background: Inflammatory bowel disease can develop with some rheumatic diseases in childhood, including juvenile idiopathic arthritis (JIA). Systemic onset JIA has not been connected to inflammatory bowel disease (IBD), but might be connected especially in the context of new treatments. Methods: [for full text, please go to the a.m. URL]<br/>44. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh); 30. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh); 26. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)<br/>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (19)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....